Tirzepatide
Tirzepatide belongs to the dual GIP and GLP-1 receptor agonist class, offering a unique approach to blood sugar control and weight management. By activating these receptors, tirzepatide helps regulate glucose levels, reduces appetite, and extends the feeling of fullness after meals.*
*Tirzepatide is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate